SIRT1 promotes proliferation and inhibits the senescence-like phenotype in human melanoma cells - Archive ouverte HAL Access content directly
Journal Articles Oncotarget Year : 2014

SIRT1 promotes proliferation and inhibits the senescence-like phenotype in human melanoma cells

(1) , (1) , (1) , (1) , (2) , (3) , (3) , (1) , (1)
1
2
3

Abstract

SIRT1 operates as both a tumor suppressor and oncogenic factor depending on the cell context. Whether SIRT1 plays a role in melanoma biology remained poorly elucidated. Here, we demonstrate that SIRT1 is a critical regulator of melanoma cell proliferation. SIRT1 suppression by genetic or pharmacological approaches induces cell cycle arrest and a senescence-like phenotype. Gain and loss of function experiments show that M-MITF regulates SIRT1 expression, thereby revealing a melanocyte-specific control of SIRT1. SIRT1 over-expression relieves the senescence-like phenotype and the proliferation arrest caused by MITF suppression, demonstrating that SIRT1 is an effector of MITF-induced proliferation in melanoma cells. Interestingly, SIRT1 level and activity are enhanced in the PLX4032-resistant BRAF(V600E)-mutated melanoma cells compared with their sensitive counterpart. SIRT1 inhibition decreases melanoma cell growth and rescues the sensibility to PLX4032 of PLX4032-resistant BRAF(V600E)-mutated melanoma cells. In conclusion, we provide the first evidence that inhibition of SIRT1 warrants consideration as an anti-melanoma therapeutic option.
Fichier principal
Vignette du fichier
1791-17804-3-PB.pdf (2.28 Mo) Télécharger le fichier
Origin : Publisher files allowed on an open archive
Loading...

Dates and versions

inserm-02530589 , version 1 (03-04-2020)

Identifiers

Cite

Mickaël Ohanna, Caroline Bonet, Karine Bille, Maryline Allegra, Irwin Davidson, et al.. SIRT1 promotes proliferation and inhibits the senescence-like phenotype in human melanoma cells. Oncotarget, 2014, 5 (8), pp.2085-95. ⟨10.18632/oncotarget.1791⟩. ⟨inserm-02530589⟩
30 View
28 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More